The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions
PS Cannon, B O'Donnell, SC Huilgol… - British journal of …, 2011 - bjo.bmj.com
Aim To describe the ophthalmic side-effects of topical imiquimod for periocular actinic
keratoses, squamous cell carcinoma in situ and basal cell carcinoma. Method A …
keratoses, squamous cell carcinoma in situ and basal cell carcinoma. Method A …
The use of imiquimod in the treatment of periocular tumours
AH Ross, CTC Kennedy, C Collins, RA Harrad - Orbit, 2010 - Taylor & Francis
Purpose: To review our experience with 5% topical Imiquimod in the treatment of periocular
tumours. Methods: Imiquimod, an imidazoquinoline, is an immune response modifier which …
tumours. Methods: Imiquimod, an imidazoquinoline, is an immune response modifier which …
Topical imiquimod for periocular lentigo maligna
H Demirci, CL Shields, CG Bianciotto, JA Shields - Ophthalmology, 2010 - Elsevier
PURPOSE: To evaluate the efficacy of topical imiquimod 5%, a local immune response
modifier, in the treatment of periocular lentigo maligna. DESIGN: Retrospective …
modifier, in the treatment of periocular lentigo maligna. DESIGN: Retrospective …
Summary of actinic keratosis studies with imiquimod 5% cream
H Tran, K Chen, S Shumack - British Journal of Dermatology, 2003 - academic.oup.com
Imiquimod is being investigated as a therapeutic option for the management of actinic
keratosis. Three recent clinical trials have demonstrated a reasonable efficacy rate and high …
keratosis. Three recent clinical trials have demonstrated a reasonable efficacy rate and high …
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the …
J Jorizzo, S Dinehart, R Matheson, JK Moore… - Journal of the American …, 2007 - Elsevier
BACKGROUND: A shorter dosing regimen of imiquimod for the treatment of actinic keratosis
may be effective, with long-term clinical benefits. OBJECTIVE: Imiquimod in one or two …
may be effective, with long-term clinical benefits. OBJECTIVE: Imiquimod in one or two …
Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the …
JK Rivers, L Rosoph, N Provost… - Journal of cutaneous …, 2008 - journals.sagepub.com
Background: Local skin reactions are common during imiquimod treatment of actinic
keratosis (AK). Cyclical application of imiquimod may improve tolerability while maintaining …
keratosis (AK). Cyclical application of imiquimod may improve tolerability while maintaining …
Topical therapy with imiquimod for eyelid lesion
HH Tsang, NT Huynh… - Clinical & experimental …, 2006 - Wiley Online Library
Herein a case of clinically diagnosed lower eyelid lesion treated with topical imiquimod is
reported. Macroscopic resolution of the lesion occurred 4 weeks after treatment with good …
reported. Macroscopic resolution of the lesion occurred 4 weeks after treatment with good …
Vehicle‐controlled, randomized, double‐blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of …
A Alomar, J Bichel, S McRae - British Journal of Dermatology, 2007 - academic.oup.com
Background Imiquimod has been investigated as a safe and effective therapeutic option for
the treatment of actinic keratosis (AK). Objectives To evaluate imiquimod vs. vehicle applied …
the treatment of actinic keratosis (AK). Objectives To evaluate imiquimod vs. vehicle applied …
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
F Flowers - International journal of dermatology, 2008 - search.ebscohost.com
The article reports on the use of imiquimod 5% cream to treat actinic keratosis and other
intraepithelial neoplasms. The cream is found to stimulate innate and cell mediated immune …
intraepithelial neoplasms. The cream is found to stimulate innate and cell mediated immune …
Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists.
R Strohal, H Kerl, L Schuster - Journal of Drugs in Dermatology …, 2012 - europepmc.org
Background While randomized, controlled trials have generated information about the safety
and efficacy of imiquimod 5% cream in the treatment of actinic keratosis, still very little is …
and efficacy of imiquimod 5% cream in the treatment of actinic keratosis, still very little is …